주식회사 엔비피헬스케어

{
  "address": "경기도 수원시",
  "ceo_name": "이창규",
  "certificate": [
    {
      "cert_number": "20100101662",
      "changes": "",
      "disclosure_date": "2010-03-05",
      "first_cert_date": "2010-03-05",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2010-03-05 ~ 2012-03-04"
    },
    {
      "cert_number": "20120103541",
      "changes": "",
      "disclosure_date": "2012-04-20",
      "first_cert_date": "2010-03-05",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2012-04-20 ~ 2014-04-19"
    },
    {
      "cert_number": "20170100325",
      "changes": "",
      "disclosure_date": "2017-01-16",
      "first_cert_date": "2010-03-05",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2017-01-16 ~ 2019-01-15"
    },
    {
      "cert_number": "20190101102",
      "changes": "",
      "disclosure_date": "2019-02-15",
      "first_cert_date": "2010-03-05",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2019-01-16 ~ 2021-01-15"
    },
    {
      "cert_number": "20210101669",
      "changes": "",
      "disclosure_date": "2021-02-24",
      "first_cert_date": "2010-03-05",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2021-01-16 ~ 2023-01-15"
    },
    {
      "cert_number": "20230222020001",
      "changes": "",
      "disclosure_date": "2023-02-22",
      "first_cert_date": "2010-03-05",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2023-01-16 ~ 2026-01-15"
    },
    {
      "cert_number": "20260204020006",
      "changes": "",
      "disclosure_date": "2026-02-04",
      "first_cert_date": "2010-03-05",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2026-01-16 ~ 2029-01-15"
    }
  ],
  "company_name": "주식회사 엔비피헬스케어",
  "corp_no": "135111-*******",
  "financials": {
    "2022": {
      "capital_stock": 2092225000,
      "cost_of_sales": 574800000,
      "current_assets": 4465583000,
      "current_liabilities": 8719603000,
      "gross_profit": 9462218000,
      "net_income": -797723000,
      "net_income_bs": -797724000,
      "non_current_assets": 6693922000,
      "non_current_liabilities": 1253587000,
      "non_operating_expenses": 691620000,
      "non_operating_income": 67035000,
      "operating_profit": -173138000,
      "revenue": 10037018000,
      "sga_expenses": 9635356000,
      "total_assets": 11159505000,
      "total_equity": 1186315000,
      "total_liabilities": 9973190000
    },
    "2023": {
      "capital_stock": 2092225000,
      "cost_of_sales": 472316000,
      "current_assets": 6072443000,
      "current_liabilities": 11081898000,
      "gross_profit": 11803997000,
      "net_income": -542864000,
      "net_income_bs": -542864000,
      "non_current_assets": 8002214000,
      "non_current_liabilities": 1125867000,
      "non_operating_expenses": 673999000,
      "non_operating_income": 154607000,
      "operating_profit": -23472000,
      "revenue": 12276313000,
      "sga_expenses": 11827470000,
      "total_assets": 14074657000,
      "total_equity": 1866892000,
      "total_liabilities": 12207765000
    },
    "2024": {
      "capital_stock": 2092225000,
      "cost_of_sales": 1496402000,
      "current_assets": 5439476000,
      "current_liabilities": 12624537000,
      "gross_profit": 13611679000,
      "net_income": -2166954000,
      "net_income_bs": -2166954000,
      "non_current_assets": 8219580000,
      "non_current_liabilities": 1334581000,
      "non_operating_expenses": 538501000,
      "non_operating_income": 126973000,
      "operating_profit": -1755426000,
      "revenue": 15108081000,
      "sga_expenses": 15367105000,
      "total_assets": 13659056000,
      "total_equity": -300062000,
      "total_liabilities": 13959118000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "연구개발(의약품, 건강기능식품)",
  "phone": "031-895-****",
  "years": [
    2024,
    2023,
    2022
  ]
}